المؤلفون: Yuhui Huang, C. Fan, Tai Hato, Rakesh R. Ramjiawan, Thomas Reiberger, Dan G. Duda, Nabeel Bardeesy, Andrew X. Zhu, Rakesh K. Jain, P. Huang, Elizabeth C. Unan, C. Yunching, R.R. Ng, Tejaswini P. Reddy

المصدر: Journal of Hepatology. 62:S416

مصطلحات موضوعية: Sorafenib, Tumor microenvironment, Hepatology, business.industry, medicine.medical_treatment, Anti pd 1, Immunotherapy, medicine.disease, CXCR4, Hepatocellular carcinoma, Immunology, medicine, Cancer research, business, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::2a9dd86b212ea5b8e75d02811385939e
https://doi.org/10.1016/s0168-8278(15)30504-3